theheart.org: Hypertension studies and news. Partnership with ASH

Programs

The selected article could not be found. Try again later or contact administrator.

Sort by

Page

Showing 1 - 7 of 7 documents.

Hypertension

Emerging Options for Hypertensive Patients With Osteoarthritis

1 COMMENT - Aug 25, 2009 13:14 EDT

Join Drs Giles, Elliott, Mason and White as they discuss a new approach to preservation of NO offered by the cyclooxygenase-inhibiting nitric oxide donating (CINOD) drugs, which may have an important role in treating arthritis patients with hypertension.

Hypertension

Beyond Control of Hypertension to Prevention of Renal Damage

2 COMMENTS - Jul 30, 2009 14:55 EDT

Read Dr. Kalaitzidis' review of the role of hypertension in the cardiovascular risk continuum, then watch Drs. Weber, Mancia, Williams, and Haller as they present the latest treatment options and preview important clinical trial data.

Hypertension

Crossroads of Risk - Hypertension and Diabetes

2 COMMENTS - Jun 29, 2009 10:07 EDT

Microalbuminuria does not only signal worsening renal function but is an important marker in cardiovascular risk assessment. Join our expert panel, Drs. Izzo, Ruilope, and Weir as they discuss the interplay of diabetes and hypertension on the cardiovascular risk continuum.

Hypertension

Obstacles to Gaining Control of Hypertension

1 COMMENT - Jun 19, 2009 12:00 EDT

Join Drs. Weber, Basile, and Gradman as they discuss methods of overcoming clinical inertia and strategies to ensure that more patients achieve their blood pressure goals.

Hypertension

Analyzing the ACE/ARB Combo Concern

13 COMMENTS - Apr 24, 2009 12:00 EDT

Inhibiting the RAS: how much and for what indications? Is there consensus?

Hypertension

ARBs The Weight of the Evidence

4 COMMENTS - Dec 17, 2008 08:00 EST

From prehypertension to heart failure the data from ARB outcome trials continue to accumulate. So what's next? With Drs Giles and Izzo

Hypertension

A focus on nitric oxide

19 COMMENTS - May 30, 2008 11:16 EDT

Hypertension, hypercholesterolemia, insulin resistance, atherosclerosis, coronary heart disease, heart failure: are they all at the mercy of nitric oxide? Join Drs Weber, Cohn, Mason and Cockcroft in a discussion on the role nitric oxide plays in vascular health.

Previews

Featured programs

Inside: Hypertension

Hypertension

Beyond Control of Hypertension to Prevention of Renal Damage

2 COMMENTS - Jul 30, 2009 14:55 EDT

Hypertension

Crossroads of Risk - Hypertension and Diabetes

2 COMMENTS - Jun 29, 2009 10:07 EDT

Hypertension

Analyzing the ACE/ARB Combo Concern

13 COMMENTS - Apr 24, 2009 12:00 EDT

Inhibiting the RAS: how much and for what indications? Is there consensus?

Hypertension

Emerging Options for Hypertensive Patients With Osteoarthritis

1 COMMENT - Aug 25, 2009 13:14 EDT

Hypertension

Legacy and Innovation: New Options in the Treatment of Hypertension in Canada

8 COMMENTS - Feb 26, 2009 10:53 EST

In the past year results of new outcome trials, particularly those involving angiotensin receptor blockers have enhanced the knowledge base for these therapeutic agents. At the same time new additions to the array of antihypertensive medications such as olmesartan offer new tools and the potential for physicians to improve control rates and make more qualified decisions for patients with uncontrolled hypertension with and without comorbidities.

We comply with the HONcode standard
for trustworthy health information: verify here.

	No
	Yes